[1]
Nasehi, M.M. et al. 2022. The preventive Effectiveness of Rituximab in Pediatric Autoimmune and Inflammatory CNS Diseases Relapse: an Iranian Experience. Iranian Journal of Child Neurology. 16, 3 (Jul. 2022), 167–182. DOI:https://doi.org/10.22037/ijcn.v16i3.29322.